Citigroup Inc Apollo Endosurgery, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$9.83 - $9.96 $3.8 Million - $3.85 Million	-386,557 Reduced 16.2%	2,000,000 $19.8 Million
Q4 2022 Feb 09, 2023	BUY	$5.91 - $10.14 $2.22 Million - $3.81 Million	376,119 Added 18.71%	2,386,557 $23.8 Million
Q3 2022 Nov 10, 2022	BUY	$3.65 - $6.74 $1.5 Million - $2.77 Million	410,438 Added 25.65%	2,010,438 $11.1 Million
Q2 2022 Aug 10, 2022	BUY	$3.65 - $6.04 $1.66 Million - $2.74 Million	453,985 Added 39.61%	1,600,000 $5.84 Million
Q1 2022 May 12, 2022	BUY	$5.01 - $8.77 $5.53 Million - $9.68 Million	1,103,319 Added 2584.13%	1,146,015 $6.93 Million
Q4 2021 Feb 10, 2022	BUY	$7.64 - $10.11 $326,197 - $431,656	42,696 New	42,696 $360,000

527K

Ticker APEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,686,500
Description
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.